Occlutech Holding, a specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of Swedish Depositary Receipts (SDRs) worth SEK 450 million (
Tags :Baker McKenzie
Baker McKenzie advised Chord Therapeutics (Chord) and its shareholders on the sale of all the shares in Chord to Merck KGaA (Merck). The acquisition is subject to regulatory clearances. This strategic acquisition will enable Merck
Baker McKenzie advised Galenica Group (Galenica) on the sale and leaseback of the property at its headquarters in Berne to a Credit Suisse Asset Management real estate fund for around CHF 40 million. ADVISORING TEAM Baker
Baker McKenzie advised Deka Immobilien Investment (“Deka”) on its successful acquisition of the EK2 building, a major warehouse and logistics building near Geneva, from a Compagnie des Parcs subsidiary. The EK2 building is a ground
Merck, a global science and technology company, has entered into an agreement to acquire Chord Therapeutics, a Swiss-based biotech company focused on rare neuroinflammatory diseases. With this step, Merck expands its neurology pipeline with the
Foodstuff company Hochdorf and its pension fund have entered into agreements with the Municipality of Hochdorf on the sale of its production site in Hochdorf, in the canton of Lucerne. The sale of the land
The first Swiss SPAC, VT5 Acquisition Company, successfully priced its initial public offering. The listing of the Class A Shares and Redeemable Warrants on
UBS has signed an agreement to sell UBS Swiss Financial Advisers (UBS SFA) to Vontobel, a global investment firm. UBS SFA is a Swiss-based SEC-registered investment advisor and FINMA-licensed securities firm for US clients seeking
Zur Rose Group, e-commerce pharmacy and medical wholesalers, has concluded its accelerated bookbuilding (ABB) with the issuance of 650’000 new shares at an offer price of CHF 290 and gross proceeds of CHF 188.5 million. The shares were
Baker McKenzie advised Swisscanto (CH) Real Estate Fund Responsible Swiss Commercial (“Fund”) on the sale of the property “Werkplatz Altenrhein” in Altenrhein near St. Gallen, one of the largest properties in the Fund’s portfolio
